Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;67(6):1557-1566.
doi: 10.1007/s00234-025-03651-9. Epub 2025 May 20.

Comparative analysis of Onyx, squid, and n-BCA in middle meningeal artery embolization for chronic subdural hematoma: a meta-analysis of randomized controlled trials

Affiliations
Review

Comparative analysis of Onyx, squid, and n-BCA in middle meningeal artery embolization for chronic subdural hematoma: a meta-analysis of randomized controlled trials

Ali Mortezaei et al. Neuroradiology. 2025 Jun.

Abstract

Background: Selection of an embolic agent for middle meningeal artery embolization (MMAE) in a chronic subdural hematoma (cSDH) is a subject of debate and is limited to observational data. We report the first meta-analysis that exclusively assessed randomized controlled trials (RCTs) to address this gap.

Methods: A systematic review and meta-analysis was conducted, incorporating all available RCTs that compared MMAE plus standard of care (SOC) versus SOC alone for cSDH usingeither Onyx, n-BCA, and Squid as embolic agent for embolization. Primary outcomes were the rate of hematoma recurrence/progression and the need for reoperation. Secondary outcomes included serious adverse events (SAE), all-cause mortality, functional independence (defined as a Modified Rankin Scale (mRS) score of 0-2), and the rate of successful embolization. To assess heterogeneity, a fixed-effect or random-effects model was applied, depending on statistical significance (I²>50%, P < 0.1).

Results: Four RCTs, with 894 patients in the MMAE plus SOC group and 914 patients in the SOC alone group, were identified and met our standard for analysis. Results revealed significant superiority of n-BCA compared to Onyx and Squid in lower all-cause mortality at last follow-up. There was no significant difference in using Onyx, Squid, and n-BCA in recurrence at the last follow-up (P = 0.36), reoperation at the last follow-up (P = 0.55), and successful embolization (P = 0.52), and 90-day functional independence (P = 0.076) between trials. Additionally, further analysis on safety outcomes showed no significant difference between embolic agents in SAE at last follow-up (P = 0.78), embolization-related complications (P = 0.087), new onset ischemic stroke (P = 0.98), and deep venous thrombosis (P = 0.94).

Conclusion: This meta-analysis of RCTs suggests that while n-BCA is associated with lower all-cause mortality compared to Onyx and Squid in MMAE for cSDH, all three embolic agents demonstrate comparable efficacy and safety.

Keywords: Chronic subdural hematoma; Embolic agents; Middle meningeal artery embolization; Onyx; Squid; n-BCA.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics and consent to participate declarations: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Chen H, Colasurdo M, Kan PT (2023) Middle meningeal artery embolization as standalone treatment versus combined with surgical evacuation for chronic subdural hematomas: systematic review and meta-analysis. Published Online September 29. https://doi.org/10.3171/2023.7.JNS231262
    1. Moshayedi P, Liebeskind DS (2020) Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in trial design. Front Neurol 11. https://doi.org/10.3389/fneur.2020.00923
    1. Kan P (2024) Middle meningeal artery embolization and nonacute subdural hematoma. N Engl J Med. Published Online November 20. https://doi.org/10.1056/NEJMe2410915
    1. Abouzari M, Rashidi A, Rezaii J et al (2007) The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 61(4):794–797 discussion 797. https://doi.org/10.1227/01.NEU.0000298908.94129.67 - DOI - PubMed
    1. Oh HJ, Lee KS, Shim JJ, Yoon SM, Yun IG, Bae HG (2010) Postoperative course and recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 48(6):518–523. https://doi.org/10.3340/jkns.2010.48.6.518 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources